摘要
以广西隆安县1987至1995年间乙肝疫苗免疫的系列资料为基础,采用成本效益分析方法对乙肝血源疫苗低剂量免疫策略的成本效益进行分析评价。结果表明:隆安县1987年实施低剂量免疫策略能获得944万元的净效益,BCR为6372;灵敏度分析其BCR值始终大于1,乙肝疫苗免疫预防经济效益十分稳定。但如果无限制提高筛检费用,将失去这种效益,建议卫生行政部门加强管理。
We used the Cost Benefit analysis method to examine and evaluate the cost and effect of plasma-derived hepatitis B vaccine about the low dosage immunization strategy in Longan county,Guangxi province in 1987.The result of CBA showed that a total of 9440 thousand yuan of net benefit(NB)had been obtained from the input of 150.5 thousand yuan cost,the benefit cost ratio(BCR)was 63.72;Through sensitivity analysis of some an certain factors,all of the BCRs were more than 1.It suggests that the economic benefits of hepatitis B vaccine are outstanding and quite stable.But the immunoprophylaxis was not profitable if the screen expense were too high.The management should be strenghtened by the health administrative department.
出处
《中国公共卫生》
CAS
CSCD
北大核心
1999年第8期762-764,共3页
Chinese Journal of Public Health
基金
美国中华医学基金会
关键词
乙肝疫苗
免疫策略
成本效益分析
Hepatitis B vaccine\ Vaccinatiion strategy\ Cost-benefit Analysis(CBA)